An assay platform that robustly and sensitively quantifies the kinetics of endogenous protein turnover and target engagement is crucial for…
Read MoreSearch results: “Arg”
Showing 37–48 of 136 results
The cAMP detection technologies are widely used in high throughput screening (HTS) for measuring a functional response of a GPCR…
Read MoreAssays that directly detect compound binding inside cells can be of great utility in translating in vitro data to more…
Read MoreIt is well established that ligand binding can protect proteins from thermal denaturation in a cellular milieu; however, the broad…
Read MoreAn assay platform that robustly and sensitively quantifies the kinetics of endogenous protein turnover is crucial for discovery of disease-relevant…
Read MorePresented by Dr. Alexander Baumann Head of European Business Development Eurofins DiscoverXProducts
Read MoreJane E. Lamerdin, Ph.D. Vice President, Research & Development Eurofins DiscoverX
Read MoreGaurav Agrawal, Ph.D.Scientific Development Manager
Read MoreAntibody-dependent cell-mediated cytotoxicity (ADCC) is the mechanism by which many Class I therapeutic antibodies, including rituximab and trastuzumab, achieve clinical…
Read MoreWatch Recorded Presentation Jane Lamerdin, Ph.D. Director R&D, Eurofins DiscoverX
Read MoreKsenya Cohen Katsenelson, Ph.D. Group Leader, R&D, San Diego Chao-Tsung Yang, Ph.D. Principal Scientist, R&D, Fremont
Read MoreKsenya Cohen Katsenelson, Ph.D. Group Leader, R&D, Eurofins Discovery, San Diego, CA Chao-Tsung Yang, Ph.D. Group Leader, R&D, Eurofins DiscoverX,…
Read More